Skip to main content
. 2023 Jun 15;12(7):1823–1834. doi: 10.1007/s40121-023-00829-7
Why carried out this study?
Antimicrobial consumption (AMC) has declined in Japan in recent years.
However, we do not know whether or not the disease burden due to antimicrobial resistance (AMR) has been mitigated.
What was learned from this study?
Disease burden due to AMR in Japan did not decrease during the study period (2015–2020).
A decrease in AMC might not be a sufficient AMR countermeasure.